Form EFFECT Biodexa Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2026 |
| Accession Number: | 0001214659-26-003931 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lightmatter Delivers Open Rack CPO Switch and XPU Scale-Up Server Through Independent Collaborations with Flex and Other Industry Partners
- Plume Cleaning Services Introduces Absolute Clean, Raising the Standard for Home Cleaning on the Central Coast of New South Wales
- Best Enterprise Fine-Tuning Services (2026) Report Published by Metaclade Research
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share